Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3924502
Max Phase: Preclinical
Molecular Formula: C18H12FNO5
Molecular Weight: 341.29
Molecule Type: Small molecule
Associated Items:
ID: ALA3924502
Max Phase: Preclinical
Molecular Formula: C18H12FNO5
Molecular Weight: 341.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(c1cccc(-c2cccc(O)c2F)n1)c1ccc(O)c(O)c1O
Standard InChI: InChI=1S/C18H12FNO5/c19-15-9(3-1-6-13(15)21)11-4-2-5-12(20-11)16(23)10-7-8-14(22)18(25)17(10)24/h1-8,21-22,24-25H
Standard InChI Key: NDIMTZCJOPCTRD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 341.29 | Molecular Weight (Monoisotopic): 341.0700 | AlogP: 2.94 | #Rotatable Bonds: 3 |
Polar Surface Area: 110.88 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.09 | CX Basic pKa: 0.70 | CX LogP: 4.21 | CX LogD: 3.64 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.43 | Np Likeness Score: -0.06 |
1. Braun F, Bertoletti N, Möller G, Adamski J, Steinmetzer T, Salah M, Abdelsamie AS, van Koppen CJ, Heine A, Klebe G, Marchais-Oberwinkler S.. (2016) First Structure-Activity Relationship of 17β-Hydroxysteroid Dehydrogenase Type 14 Nonsteroidal Inhibitors and Crystal Structures in Complex with the Enzyme., 59 (23): [PMID:27933965] [10.1021/acs.jmedchem.6b01436] |
Source(1):